Paradigm Biopharmaceuticals Limited (PAR) is an Australian biopharmaceutical company focused on repurposing the drug ‘pentosan polysulphate sodium’ (PPS) for the treatment of bone marrow edema. Paradigm is targeting addressable markets with the aim to use the shortened development pathway utilising repurposed drugs.
Paradigm Biopharmaceuticals Limited operators in Health Care sector and under industry of Biotechnology. The company website is: http://www.paradigmbiopharma.com.
You can also check out dividend history for similar stocks in the same sector as follows:
PAR Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found